ADAR1 as a Placental Innate Immune Rheostat Sustaining the Homeostatic Balance of Intrinsic Interferon Response at the Maternal-Fetal Interface.

Adv Sci (Weinh)

Fujian Provincial Key Laboratory of Reproductive Health Research, Cancer Research Center, Department of Obstetrics and Gynecology, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, Fujian, 361102, China.

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The mechanisms that balance a robust intrinsic antiviral defense at the maternal-fetal interface with fetal development remain elusive. Here, it is delineated that ADAR1, an adenosine-to-inosine (A-to-I) editor, fine-tunes intrinsic interferon (IFN)-mediated integrates stress response (ISR) in the mouse placenta, thereby orchestrating embryonic development and antiviral defense. Placental Adar1 deletion (Adar1) trigger spatially resolved overwhelming IFN responses, which impair the differentiation of IFN hyper-responsive junctional zone (JZ) progenitors and functions of the placental JZ, ultimately causing embryonic death. Mechanistically, the Adar1 placental IFN hyper-response is positively amplified by the accumulated immunogenic dsRNAs from the 3'UTR of interferon-stimulated genes (ISG-3'UTR-dsRNA). The resulting fetal death is rescued by concurrent deletion of Mavs, Ifnar1, or Pkr, but not Zbp1 or cell death effectors. Notably, blocking ISR pharmacologically preventes embryonic lethality induced by Adar1 JZ defects. These findings demonstrate that ADAR1 fine-tunes the unique spatially resolved IFN-PKR-ISR signaling in the placenta by restricting ISG-3'UTR-dsRNA accumulation, highlighting a potential therapeutic strategy for treating interferonopathy-associated pregnancy complications.

Download full-text PDF

Source
http://dx.doi.org/10.1002/advs.202505491DOI Listing

Publication Analysis

Top Keywords

adar1 placental
8
intrinsic interferon
8
maternal-fetal interface
8
antiviral defense
8
spatially resolved
8
adar1
7
placental innate
4
innate immune
4
immune rheostat
4
rheostat sustaining
4

Similar Publications

ADAR1 as a Placental Innate Immune Rheostat Sustaining the Homeostatic Balance of Intrinsic Interferon Response at the Maternal-Fetal Interface.

Adv Sci (Weinh)

August 2025

Fujian Provincial Key Laboratory of Reproductive Health Research, Cancer Research Center, Department of Obstetrics and Gynecology, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, Fujian, 361102, China.

The mechanisms that balance a robust intrinsic antiviral defense at the maternal-fetal interface with fetal development remain elusive. Here, it is delineated that ADAR1, an adenosine-to-inosine (A-to-I) editor, fine-tunes intrinsic interferon (IFN)-mediated integrates stress response (ISR) in the mouse placenta, thereby orchestrating embryonic development and antiviral defense. Placental Adar1 deletion (Adar1) trigger spatially resolved overwhelming IFN responses, which impair the differentiation of IFN hyper-responsive junctional zone (JZ) progenitors and functions of the placental JZ, ultimately causing embryonic death.

View Article and Find Full Text PDF

The adenosine deaminase family acting on RNA 1 can be a useful diagnostic biomarker in chorioamnionitis.

Placenta

August 2024

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.

Article Synopsis
  • Chorioamnionitis (CAM) is an infection and inflammation of the membranes surrounding the fetus, but effective diagnostic biomarkers are currently lacking.!* -
  • The study examined the role of the RNA editing enzyme ADAR1 in diagnosing CAM by analyzing specimens from patients with premature rupture of membranes and diagnosed CAM using RT-PCR.!* -
  • Results showed that ADAR1 levels were significantly higher in CAM patients, suggesting it could serve as a reliable diagnostic biomarker compared to existing inflammatory and clinical markers.!*
View Article and Find Full Text PDF

Z-DNA-forming silencer in the first exon regulates human ADAM-12 gene expression.

Proc Natl Acad Sci U S A

January 2011

Department of Veterinary Pathobiology, University of Missouri, Columbia, MO 65211, USA.

Upregulation of ADAM-12, a novel member of the multifunctional ADAM family of proteins is linked to cancer, arthritis and cardiac hypertrophy. Basal expression of ADAM-12 is very low in adult tissues but rises markedly in response to certain physiological cues, such as during pregnancy in the placenta, during development in neonatal skeletal muscle and bone and in regenerating muscle. Studies on ADAM-12 regulation have identified a highly conserved negative regulatory element (NRE) at the 5'-UTR of human ADAM-12 gene, which acts as a transcriptional repressor.

View Article and Find Full Text PDF

Human RNA-specific adenosine deaminase (ADAR1) gene specifies transcripts that initiate from a constitutively active alternative promoter.

Gene

November 2000

Department of Molecular, Cellular, and Developmental Biology and Interdepartmental Graduate Program of Biochemistry and Molecular Biology, University of California, Santa Barbara, CA 93106, USA.

The human ADAR1 gene specifies two size forms of RNA-specific adenosine deaminase, an interferon (IFN) inducible approximately 150 kDa protein and a constitutively expressed N-terminally truncated approximately 110 kDa protein, encoded by transcripts with alternative exon 1 structures that initiate from different promoters. We have now identified a new class of ADAR1 transcripts, with alternative 5'-structures and a deduced coding capacity for the approximately 110 kDa protein. Nuclease protection and 5'-rapid amplification of cDNA ends (5'-RACE) revealed five major ADAR1 transcriptional start sites that mapped within the previously identified and unusually large (approximately 1.

View Article and Find Full Text PDF

RNA-specific adenosine deaminase (ADAR1) catalyzes the deamination of adenosine to inosine in viral and cellular RNAs. Two size forms of the ADAR1 editing enzyme are known, an IFN-inducible approximately 150-kDa protein and a constitutively expressed N-terminally truncated approximately 110-kDa protein. We have now identified alternative exon 1 structures of human ADAR1 transcripts that initiate from unique promoters, one constitutively expressed and the other IFN inducible.

View Article and Find Full Text PDF